Taiwan Bulk Drug Production Drives Healthy First Five Months
This article was originally published in PharmAsia News
Executive Summary
Taiwan's bulk-drug production increased by more than a third for the first five months of this year, leading to an overall 6.7 percent increase in pharmaceutical production, according to Industry and Technology Intelligence Services. During the period, ITIS said, the value of the production rose to $759.2 million. Production of Western pharmaceuticals rose only 0.9 percent between January and May, the poor growth rate blamed on government policy that adjusted co-payments for drugs from that sector. An ITIS analyst said he expected the industry's overall production to continue to experience stable growth for the rest of this year, led again by an expected surge in active pharmaceutical ingredients exports. (Click here for more